Akinkunmi Paul Okekunle1, Ying Li1, Liyan Liu1, Shanshan Du1, Xiaoyan Wu1, Yang Chen1, Yanchuan Li1, Jiayue Qi1, Changhao Sun2, Rennan Feng3. 1. Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang Province 150081, People's Republic of China. 2. Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang Province 150081, People's Republic of China. Electronic address: changhao2002sun@gmail.com. 3. Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang Province 150081, People's Republic of China. Electronic address: fengrennan@163.com.
Abstract
AIM: To evaluate circulating amino acids (AA) profiles in obesity, type 2 diabetes (T2D) and metabolic syndrome (MetS). METHODS: Serum AA were profiled among 200; healthy, obese, T2D and MetS subjects matched by sex, age and BMI using ultra-high performance liquid chromatography tandem quadruple mass spectrometry (UPLC-TQ-MS). A meta-analysis, including 47 case-control studies (including the current study) on serum AA in obesity, T2D and MetS searched through October 2016 was conducted to explore the AA differences in obesity, T2D and MetS. RESULTS: In comparison with healthy controls, 14 AA (10 increased and 4 decreased) were significantly altered (P<0.05) in all non-healthy subjects. Also, mean differences of valine (obese: 34.13 [27.70, 40.56]µmol/L, P<0.001, T2D: 19.49 [3.31, 35.68]µmol/L, P<0.05, MetS: 29.18 [16.04, 42.33]µmol/L, P<0.001), glutamic acid (obese: 18.62 [11.64, 25.61]µmol/L, P<0.001, T2D: 19.94 [0.28, 39.61]µmol/L, P<0.05, MetS: 12.45 [3.98, 20.91]µmol/L, P<0.001), proline (obese: 16.72 [6.20, 27.24]µmol/L, P<0.001, T2D: 20.72 [15.82, 25.61]µmol/L, P<0.001, MetS: 29.95 [25.18, 34.71]µmol/L, P<0.001) and isoleucine (obese: 11.39 [8.54, 14.24]µmol/L, P<0.001, T2D: 7.37 [1.52, 13.22]µmol/L, P<0.05, MetS: 10.40 [4.90, 15.89]µmol/L, P<0.001) were significantly higher compared to healthy controls. Similarly, mean differences of glycine (obese: -30.99 [-39.69, -22.29]µmol/L, P<0.001, T2D: -30.37 [-41.80, -18.94]µmol/L, P<0.001 and MetS: -35.24 [-39.28, -31.21]µmol/L, P<0.001) were significantly lower compared to healthy controls. CONCLUSION: In both the case-control study and meta-analysis, obesity was related to the most circulating AA changes, followed by MetS and T2D. Valine, isoleucine, glutamic acid and proline increased, while Glycine decreased in all metabolic disorders.
AIM: To evaluate circulating amino acids (AA) profiles in obesity, type 2 diabetes (T2D) and metabolic syndrome (MetS). METHODS: Serum AA were profiled among 200; healthy, obese, T2D and MetS subjects matched by sex, age and BMI using ultra-high performance liquid chromatography tandem quadruple mass spectrometry (UPLC-TQ-MS). A meta-analysis, including 47 case-control studies (including the current study) on serum AA in obesity, T2D and MetS searched through October 2016 was conducted to explore the AA differences in obesity, T2D and MetS. RESULTS: In comparison with healthy controls, 14 AA (10 increased and 4 decreased) were significantly altered (P<0.05) in all non-healthy subjects. Also, mean differences of valine (obese: 34.13 [27.70, 40.56]µmol/L, P<0.001, T2D: 19.49 [3.31, 35.68]µmol/L, P<0.05, MetS: 29.18 [16.04, 42.33]µmol/L, P<0.001), glutamic acid (obese: 18.62 [11.64, 25.61]µmol/L, P<0.001, T2D: 19.94 [0.28, 39.61]µmol/L, P<0.05, MetS: 12.45 [3.98, 20.91]µmol/L, P<0.001), proline (obese: 16.72 [6.20, 27.24]µmol/L, P<0.001, T2D: 20.72 [15.82, 25.61]µmol/L, P<0.001, MetS: 29.95 [25.18, 34.71]µmol/L, P<0.001) and isoleucine (obese: 11.39 [8.54, 14.24]µmol/L, P<0.001, T2D: 7.37 [1.52, 13.22]µmol/L, P<0.05, MetS: 10.40 [4.90, 15.89]µmol/L, P<0.001) were significantly higher compared to healthy controls. Similarly, mean differences of glycine (obese: -30.99 [-39.69, -22.29]µmol/L, P<0.001, T2D: -30.37 [-41.80, -18.94]µmol/L, P<0.001 and MetS: -35.24 [-39.28, -31.21]µmol/L, P<0.001) were significantly lower compared to healthy controls. CONCLUSION: In both the case-control study and meta-analysis, obesity was related to the most circulating AA changes, followed by MetS and T2D. Valine, isoleucine, glutamic acid and proline increased, while Glycine decreased in all metabolic disorders.
Authors: Shilpa N Bhupathiraju; Marta Guasch-Ferré; Meghana D Gadgil; Christopher B Newgard; James R Bain; Michael J Muehlbauer; Olga R Ilkayeva; Denise M Scholtens; Frank B Hu; Alka M Kanaya; Namratha R Kandula Journal: J Nutr Date: 2018-07-01 Impact factor: 4.798
Authors: Jill K Morris; Brian D Piccolo; Kartik Shankar; John P Thyfault; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2017-12-26 Impact factor: 4.310
Authors: Hong Chang Tan; Jean W Hsu; E Shyong Tai; Shaji Chacko; Vieon Wu; Chun Fan Lee; Jean-Paul Kovalik; Farook Jahoor Journal: Front Endocrinol (Lausanne) Date: 2022-06-09 Impact factor: 6.055
Authors: Dipsikha Biswas; Kathleen Tozer; Khoi T Dao; Lester J Perez; Angella Mercer; Amy Brown; Intekhab Hossain; Alexandra M Yip; Christie Aguiar; Hany Motawea; Keith R Brunt; Jennifer Shea; Jean F Legare; Ansar Hassan; Petra C Kienesberger; Thomas Pulinilkunnil Journal: Front Endocrinol (Lausanne) Date: 2020-08-07 Impact factor: 5.555
Authors: Tiago Morais; Alexandre L Seabra; Bárbara G Patrício; Marta Guimarães; Mário Nora; Pedro F Oliveira; Marco G Alves; Mariana P Monteiro Journal: Int J Mol Sci Date: 2021-05-27 Impact factor: 5.923
Authors: Martina Palomino-Schätzlein; Rafael Simó; Cristina Hernández; Andreea Ciudin; Pablo Mateos-Gregorio; Antonio Hernández-Mijares; Antonio Pineda-Lucena; José Raúl Herance Journal: PLoS One Date: 2018-07-13 Impact factor: 3.240